AA
Anup Arvind Godbole
About Anup Arvind Godbole
Data last updated:
Anup Arvind Godbole is an Additional Director at Abbvie Therapeutics India Private Limited (since 2025). The company operates in Healthcare. Abbvie Therapeutics India Private Limited reported revenue of ₹533 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 04 Dec 2025 | 1994 | ₹533 Cr (FY 2026) | Active |
Board colleagues of Anup Arvind Godbole
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Gopikisan Piramal | 00028116 | Abbvie Therapeutics India Private Limited | Director |
| Hong Liu Shi | 10424175 | Abbvie Therapeutics India Private Limited | Director |
| Kesavan Gopinath | 10307250 | Abbvie Therapeutics India Private Limited | Director |
| Perumal Chinnaiah | Abbvie Therapeutics India Private Limited | Company Secretary | |
| Suresh Pattathil | 02748206 | Abbvie Therapeutics India Private Limited | Managing Director |
| Swati Ajay Piramal | 00067125 | Abbvie Therapeutics India Private Limited | Director |
| Vidhan Kedia | 06718606 | Abbvie Therapeutics India Private Limited | Director |
| Vivek Valsaraj | 06970246 | Abbvie Therapeutics India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anup Arvind Godbole
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anup Arvind Godbole
Anup Arvind Godbole currently holds 1 directorship: Abbvie Therapeutics India Private Limited (Additional Director, since 04 Dec 2025, revenue ₹533 Cr (FY 2026)).
Anup Arvind Godbole was first appointed on 04 Dec 2025 as Additional Director at Abbvie Therapeutics India Private Limited.
The current boards of Anup Arvind Godbole's companies include Ajay Gopikisan Piramal (Abbvie Therapeutics India Private Limited), Hong Liu Shi (Abbvie Therapeutics India Private Limited), Kesavan Gopinath (Abbvie Therapeutics India Private Limited), Perumal Chinnaiah (Abbvie Therapeutics India Private Limited), Suresh Pattathil (Abbvie Therapeutics India Private Limited), Swati Ajay Piramal (Abbvie Therapeutics India Private Limited), among others.